Practice Management News

“Why should I be investing in bonds when I can earn more than 5% on my cash?” Many investors, including physicians, are asking this question after being discouraged by losses they have experienced with bonds in recent years.

Children with obesity demonstrate a greater likelihood of shock, ICU admission and worse laboratory scores in multisystem inflammatory syndrome, but not Kawasaki disease, according to data published in JAMA Network Open.

CVS Caremark, one of the nation’s largest pharmacy benefit managers, will remove Humira from its major national commercial formularies effective April 1 in favor of biosimilar options, according to a press release from the company.

Although rates of smoking have steadily declined in recent decades, 34 million Americans still use cigarettes, according to the American Cancer Society, with many of those millions being patients with autoimmune and rheumatic diseases.

What should rheumatologists know about what we've learned about COVID-19 and long COVID in 2023? Hosted by Dr. Leonard Calabrese.

Switching between biosimilars and reference products did not increase the risk for death or serious adverse events, according to a meta-analysis conducted by FDA investigators.

When choosing a structure for a practice, you are making two choices: what legal structure to choose and which tax treatment to select.

The Residency to Retirement resource center offers insightful and innovative strategies to help physicians reduce taxes, protect assets, invest wisely and build wealth during all phases of their careers.

News pertaining to biosimilars came at a fast and furious pace in 2023.

The state of pain management in rheumatology has always been in flux.